Febuxostat: a new gout therapy flares up

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1468, 2004-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Febuxostat comparable with allopurinol for gout

By  

Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Febuxostat aims for the apex of gout treatment

By  

Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Febuxostat for the Management of Hyperuricaemia in Patients with Gout: A NICE Single Technology Appraisal

By Stevenson Matt   Pandor Abdullah  

PharmacoEconomics, Vol. 29, Iss. 2, 2011-02 ,pp. : 133-140

Adis International

Access to resources Recommend Favorite

Febuxostat

By Hair Philip I.   McCormack Paul L.   Keating Gillian M.  

Drugs, Vol. 68, Iss. 13, 2008-01 ,pp. : 1865-1874

Adis International

Access to resources Recommend Favorite

Febuxostat: a non-purine, selective inhibitor of xanthine oxidase for the management of hyperuricaemia in patients with gout

By Schumacher Jr   H Ralph  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 893-903

Informa Healthcare

Access to resources Recommend Favorite